Patent assignee · US · COMPANY

SpringWorks Therapeutics, Inc.

🏢 View company profile →
41Patents
41Active
41Granted
68Portfolio score

Filing activity: Feb 17, 2021 → Oct 10, 2024

Most-cited patents

PatentTitleAreaCited byStatus
US11427534B1 Solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide and uses thereof Chemistry; Metallurgy 16 Active
US11084780B1 Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof Chemistry; Metallurgy 11 Active
US11806321B2 Non-linear dosing of mirdametinib Human Necessities 8 Active
US11872211B2 Treatments with nirogacestat Human Necessities 7 Active
US11819487B2 Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib Human Necessities 6 Active
US11571402B2 Dispersible formulations of N-((R)-2,3-dihydroxypropoly)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof Human Necessities 5 Active
US11806322B2 Mirdametinib treatment Human Necessities 4 Active
US11938116B2 Treatments with nirogacestat Human Necessities 3 Active
US11925619B2 Treatments with nirogacestat Human Necessities 3 Active
US11957662B2 Treatments with nirogacestat Human Necessities 3 Active
US11925620B1 Treatments with nirogacestat Human Necessities 3 Active
US11951096B2 Treatments with nirogacestat Human Necessities 3 Active
US12029711B1 Dosage forms of mirdametinib Human Necessities 3 Active
US11883375B2 Mirdametinib treatment Human Necessities 2 Active
US12011424B2 Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib Human Necessities 2 Active
US11884610B2 Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof Chemistry; Metallurgy 2 Active
US11839595B2 Mirdametinib treatment Human Necessities 2 Active
US12090128B2 Dispersible formulations of n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benazmide and uses thereof Human Necessities 1 Active
US11807611B2 Chlorinated tetralin compounds and pharmaceutical compositions Chemistry; Metallurgy 1 Active
US11612588B1 Chlorinated tetralin compounds and pharmaceutical compositions Chemistry; Metallurgy 1 Active
US11844780B2 Chlorinated tetralin compounds and pharmaceutical compositions Chemistry; Metallurgy 1 Active
US12247012B2 Synthesis of nirogacestat Chemistry; Metallurgy 0 Active
US12036207B2 Treatments with nirogacestat Human Necessities 0 Active
US12030866B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD Chemistry; Metallurgy 0 Active
US11780800B1 Fluorinated phenylamino compounds and pharmaceutical compositions Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.